FDA NDC Directory · JSON-LD · Markdown

Yorvipath

NDC 73362-102 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namePalopegteriparatide
Labeler / ManufacturerAscendis Pharma, Endocrinology, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA216490
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsPALOPEGTERIPARATIDE (420 ug/1.4mL)
Marketing started20240809
Package count1

External sources

Source: openFDA. Public-domain (CC0).